tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Barbora Blaha

Barbora Blaha

UBS
Wall Street Analyst
Ranked #7,245 out of 8,047 Analysts on TipRanks (#19,354 out of 21,521 overall experts)

Success Rate

14%
1 out of 7 Profitable Transactions

Average Return

-22.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Barbora Blaha's ratings since 2021 and opened each position for the duration of 1 Year:
14.29% of your transactions would have been profitable with an average return of -22.3%

Stock Rating Distribution

19Ratings
63.16% Hold
36.84% Buy
0.00% Sell
Distribution of Barbora Blaha's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
Cassiopea SpA
(CPPSF)
Rating Type:Buy
Dates:Aug 03, 2020 - Aug 03, 2021
Gain:22.90%
The most profitable rating made by Barbora Blaha

Barbora Blaha's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Cassiopea SpA
Buy
Reiterated
50%
-6.00%
2
Santhera Pharmaceuticals Holding AG
Hold
Reiterated
$3.19
(125.96% Upside)
0.00%
4
Molecular Partners
Hold
Reiterated
$19.65
(184.75% Upside)
0.00%
1
COSMO Pharmaceuticals N.V.
Buy
Reiterated
SFr.93.00
(77.70% Upside)
0%
-38.80%
2
Molecular Partners AG
Hold
Reiterated
$18.05
(216.75% Upside)
0%
-27.10%
7
Siegfried Holding AG
Buy
Reiterated
$1,153.37
(58.00% Upside)
0%
-19.90%
2
Meyer Burger Technology AG
Hold
Downgraded
$0.49
(-22.94% Downside)
0.00%
1
List of latest recommendations made by Barbora Blaha. Click to expand and see Barbora Blaha's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More